Novel findings in relation to multiple anti-atherosclerotic effects of XueZhiKang in humans-Reference-Cited by-同舟云学术

Novel findings in relation to multiple anti-atherosclerotic effects of XueZhiKang in humans

Published:2018-06 Issue:2 Volume:4 Page:117-126
ISSN:2095-882X
Container-title:Chronic Diseases and Translational Medicine
language:en
Short-container-title:Chronic Diseases and Translational Medicine

Author:

Xu Rui-Xia,Zhang Yan,Guo Yuan-Lin^ORCID,Ma Chun-Yan,Yao Yu-Hong,Li Sha,Li Xiao-Lin,Qing Ping,Gao Ying,Wu Na-Qiong,Zhu Cheng-Gang,Liu Geng,Dong Qian,Sun Jing,Li Jian-Jun

Funder

Capital Special Foundation of Clinical Application Research

Capital Health Development

Beijing Natural Science Foundation

CAMS Major Collaborative Innovation Project

PUMC

Publisher

Elsevier BV

Subject

General Medicine

Reference47 articles.

1. Aging and atherosclerosis: mechanisms, functional consequences, and potential therapeutics for cellular senescence;Wang;Circ Res,2012

2. Low Levels of High-Density Lipoprotein Cholesterol and Increased Risk of Cardiovascular Events in Stable Ischemic Heart Disease Patients

3. Evidence for low high-density lipoprotein cholesterol levels in Australian indigenous peoples: a systematic review;Lyons;BMC Public Health,2014

4. Inflammation in coronary artery diseases;Li;Chin Med J Engl,2011

5. Increased peripheral circulating inflammatory cells and plasma inflammatory markers in patients with variant angina;Li;Coron Artery Dis,2008

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in anti-inflammatory active components and action mechanisms of natural medicines;Inflammopharmacology;2023-11-10

2. Effect of Xuezhikang Therapy on Expression of Pulmonary Hypertension Related miR-638 in Patients With Low HDL-C Levels;Frontiers in Pharmacology;2021-12-20

3. Traditional Chinese medicine for acute coronary syndrome;Medicine;2021-08-20

4. Regulation of Apolipoprotein B by Natural Products and Nutraceuticals: A Comprehensive Review;Current Medicinal Chemistry;2021-02

5. A 26-week toxicological study of Xuezhikang (XZK), red yeast rice extract, in Beagle dogs with a 4-week recovery period;Regulatory Toxicology and Pharmacology;2020-11